Neos Therapeutics, Inc. (NASDAQ:NEOS) will hold its 2Q20 earnings conference call with the financial community on 10th August 2020 at 8:30 AM Eastern Time.
The conference call will be webcast live on Internet at www.neostx.com
Earnings Expectation
Neos Therapeutics, Inc. is set to announce second quarter earning results on Monday 10th August 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, NEOS to report 2Q20 loss of $ 0.13 per share. For the full year, analysts anticipate top line of $ 66.37 million, while looking forward to loss of $ 0.3 per share bottom line.
Neos Therapeutics, Inc., a pharmaceutical company, develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technology platform. Its products are extended-release (XR) medications in orally disintegrating tablets or liquid suspension dosage forms. The company manufactures and markets Adzenys XR-ODT amphetamine for the treatment of ADHD; Cotempla XR-ODT methylphenidate for treating of ADHD; Adzenys ER amphetamine to treat ADHD; and generic Tussionex hydrocodone and chlorpheniramine for cough and upper respiratory symptoms of a cold.
